Drugs / RX-af01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05576961 | Sep 2022 → Dec 2024 | cancer | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RX-af01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05576961 ↗ |
| Modality | Other / unclassified | “RX-af01 is a kind of anti-tumor intestinal bacteria” NCT05576961 ↗ |
| Route | Oral | “RX-af01: 1 capsule, bid, po, every day” NCT05576961 ↗ |